CLINICAL_TRIALS
trial_result
· 2017-05-15
Clinical Trial Update: Retapamulin Microdialysis Feasibility Study [Phase 1]
Summary
Phase 1 microdialysis feasibility study of retapamulin for bacterial skin infections has been completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Skin Infections, Bacterial | Phase 1 | Status: COMPLETED